FLAVIVACCINE EU

FLAVIVACCINE project aims at delivering safe and effective protection against mosquito-borne flavivirus infection. 

Dengue, yellow fever, Zika, and West Nile viruses persist as major threats to global public health, affecting millions annually and claiming hundreds of thousands of lives. Recognising the urgency of effective interventions, the FLAVIVACCINE project seeks to offer an innovative, safe, and effective vaccine by developing and characterising a pan-flavivirus vaccine candidate.

Instead of directly targeting the virus, the project focuses on the initial infection resulting from contact with mosquito saliva. 

Co-funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or HADEA. Neither the EU nor the granting authority can be held responsible for them.